Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Werdnig-Hoffmann Disease

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Werdnig-Hoffmann Disease

Prabhu D. Emmady et al.
Free Books & Documents

Excerpt

Werdnig-Hoffmann disease is a type of spinal muscular atrophy (SMA), a rare form of motor neuron disease. It is the most common type of SMA and accounts for about 80% of individuals with this condition. There are 4 types of SMA. Werdnig-Hoffmann disease, also known as SMA1, is the most severe form. Infants with this condition experience severe muscle weakness with onset before 6 months of age and presenting symptoms include severe motor weakness, poor muscle tone, and lack of motor development.

Motor neuron disease is a condition that affects the anterior horn cells of the motor neurons. These are the neurons that control voluntary muscle control. These are rare conditions that are often very severe, and no cure is available. Examples of motor neuron diseases include amyotrophic lateral sclerosis (ALS), progressive muscular atrophy (PMA), SMA, progressive bulbar palsy (PBP), primary lateral sclerosis (PLS), etc., These conditions spare sensory nerves, and individuals do not have sensory involvement. Individuals often have a combination of upper and lower motor neuron symptoms.

SMA is a type of motor neuron disease. SMA presents four subtypes.

  1. Werdnig-Hoffmann disease, also known as acute spinal muscular atrophy, is SMA 1.

  2. SMA2, also known as intermediate SMA and chronic infantile SMA, has less severe symptoms than SMA1 and can sit without support but cannot stand or walk. SMA2 symptom onset is in infanthood.

  3. SMA3, also known as Kugelberg-Welander disease, presents after the age of 1, and the child is able to walk initially but later has the regression of motor abilities. They often develop poor balance, falls, and scoliosis.

  4. Individuals with SMA4 have minimal symptoms compared to the other forms, and symptom onset is after the age of 10 years. They usually have a normal lifespan. They usually have normal motor milestones and mobility.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Prabhu Emmady declares no relevant financial relationships with ineligible companies.

Disclosure: Jeffrey Bodle declares no relevant financial relationships with ineligible companies.

References

    1. McDermott CJ, Shaw PJ. Diagnosis and management of motor neurone disease. BMJ. 2008 Mar 22;336(7645):658-62. - PMC - PubMed
    1. Shababi M, Lorson CL, Rudnik-Schöneborn SS. Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease? J Anat. 2014 Jan;224(1):15-28. - PMC - PubMed
    1. Farrar MA, Kiernan MC. The Genetics of Spinal Muscular Atrophy: Progress and Challenges. Neurotherapeutics. 2015 Apr;12(2):290-302. - PMC - PubMed
    1. Sedghi M, Behnam M, Fazel E, Salehi M, Ganji H, Meamar R, Hosseinzadeh M, Nouri N. Genotype-phenotype correlation of survival motor neuron and neuronal apoptosis inhibitory protein genes in spinal muscular atrophy patients from Iran. Adv Biomed Res. 2014;3:74. - PMC - PubMed
    1. Verhaart IEC, Robertson A, Wilson IJ, Aartsma-Rus A, Cameron S, Jones CC, Cook SF, Lochmüller H. Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review. Orphanet J Rare Dis. 2017 Jul 04;12(1):124. - PMC - PubMed

Publication types

LinkOut - more resources